SMTL ID : 6ti8.4 (3 other biounits)

IRAK4 IN COMPLEX WITH inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.32 Å

Oligo State

monomer

Ligands

1 x NBW: ~{N},~{N}-dimethyl-4-(1-methylcyclopropyl)oxy-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrido[3,2-d]pyrimidine-6-carboxamide(Non-covalent)

NBW.1: 19 residues within 4Å: Chain A: M.40, G.41, V.48, A.59, K.61, V.94, Y.110, V.111, Y.112, M.113, P.114, N.115, G.116, S.117, R.121, T.128, L.166, S.176, D.177 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:M.40, A:V.48, A:A.59, A:V.94, A:Y.110, A:L.166 Hydrogen bonds: A:M.113, A:M.113 Water bridges: A:D.177

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Degorce, S.L. et al., Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors. Bioorg.Med.Chem. (2020)

Release Date

2020-10-28

Peptides

Interleukin-1 receptor-associated kinase 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

Interleukin-1 receptor-associated kinase 4

Related Entries With Identical Sequence